Real World Evidence
Guidance® UTI testing is associated with reductions in critical adverse outcomes, healthcare resource utilization and cost for complicated UTI.
Study size – for standard urine culture (N=678) or Guidance UTI (N=69)
![13-lower-admissions-rate](https://pathnostics.com/wp-content/uploads/2022/04/13-lower-admissions-rate-1.png)
13%
lower rate of outpatient emergency visits
![67-lower-admissions-rate-inpatient](https://pathnostics.com/wp-content/uploads/2022/04/67-lower-admissions-rate-inpatient.png)
67%
lower inpatient admissions rate
![no-admissions-for-every-1000-patients](https://pathnostics.com/wp-content/uploads/2022/04/no-admissions-for-every-1000-patients.png)
NO
urosepsis, urgent care and skilled nursing facility admissions for every 1,000 patients in this study
![463-in-savings](https://pathnostics.com/wp-content/uploads/2022/04/463-in-savings.png)
$463.46
savings per cUTI patient tested with Guidance UTI (p=0.043)
![42-percent-reduction-in-visits](https://pathnostics.com/wp-content/uploads/2022/04/42-percent-reduction-in-visits.png)
42%
reduction in visits to emergency department, inpatient hospital, urgent care and SNF
![11-mil-savings](https://pathnostics.com/wp-content/uploads/2022/04/11-mil-savings-1.png)
$11.6 MIL
SAVINGS
for 25,000 cUTI cases